PMID- 12965124 OWN - NLM STAT- MEDLINE DCOM- 20031028 LR - 20190819 IS - 0300-483X (Print) IS - 0300-483X (Linking) VI - 191 IP - 2-3 DP - 2003 Sep 30 TI - Role of the peroxisome proliferator-activated receptor alpha in responses to diisononyl phthalate. PG - 211-25 AB - Diisononyl phthalate (DINP) is a compound widely used as a plasticizer in the production of polyvinyl chloride products. Chronic exposure to DINP leads to liver cancer in rats and mice. Many phthalates are considered to be relatively weak peroxisome proliferators (PP), a group of rodent hepatocarcinogens that cause a variety of adaptive responses in liver through the PP-activated receptor alpha (PPARalpha). The objectives of this study were to determine whether DINP-induced effects in the liver associated with carcinogenesis are mediated by PPARalpha and to identify novel gene targets of DINP. Male and female SV129 wild-type, SV129 PPARalpha-null, and B6C3F1 mice were administered DINP by gavage or in the feed. Transcript profile technology and reverse transcriptase (RT)-polymerase chain reaction (PCR) were used to identify gene targets. Dose-dependent increases in relative liver weights were dependent on PPARalpha in 10- or 12-week-old male and female mice and 30-week-old male mice. Female 30-week-old mice exhibited PPARalpha-independent increases in relative liver weights. Increases in hepatocyte proliferation, palmitoyl-CoA oxidase (PCO) activity, and levels of enzymes involved in beta- and omega-oxidation of fatty acids were shown to be dependent on PPARalpha. Five novel genes were shown to be altered in the livers of female wild-type mice after a 3-week exposure, but not in PPARalpha-null, mice. These genes included those involved in DNA repair and recombination (ATP-dependent helicase and Endonuclease III homolog), drug metabolism (Cyp2a4) and protein trafficking (FKBP-1, FKBP-13). An additional gene (Cyp2d9) was shown to be down-regulated in wild-type mice but up-regulated in PPARalpha-null mice indicating more complex regulation by PPARalpha and additional factors. These data support the hypothesis that PPARalpha plays a dominant role in mediating the effects associated with hepatocarcinogenesis after DINP exposure. FAU - Valles, Edith G AU - Valles EG AD - CIIT Centers for Health Research, Research Triangle Park, NC 27709, USA. FAU - Laughter, Ashley R AU - Laughter AR FAU - Dunn, Corrie S AU - Dunn CS FAU - Cannelle, Sabine AU - Cannelle S FAU - Swanson, Cynthia L AU - Swanson CL FAU - Cattley, Russell C AU - Cattley RC FAU - Corton, J Christopher AU - Corton JC LA - eng PT - Journal Article PL - Ireland TA - Toxicology JT - Toxicology JID - 0361055 RN - 0 (Carcinogens) RN - 0 (Phthalic Acids) RN - 0 (Plasticizers) RN - 0 (Receptors, Cytoplasmic and Nuclear) RN - 0 (Transcription Factors) RN - 4010KIX4CK (diisononyl phthalate) RN - 63231-63-0 (RNA) RN - EC 1.- (Oxidoreductases) RN - EC 1.3.3.- (palmitoyl CoA oxidase) RN - G34N38R2N1 (Bromodeoxyuridine) SB - IM MH - Animals MH - Body Weight/drug effects MH - Bromodeoxyuridine/metabolism MH - Carcinogens/toxicity MH - Cell Division/drug effects MH - Crosses, Genetic MH - Female MH - Hepatocytes/drug effects/metabolism MH - Liver Neoplasms, Experimental/*chemically induced/enzymology/genetics/metabolism MH - Male MH - Mice MH - Mice, Inbred C3H MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Oligonucleotide Array Sequence Analysis MH - Organ Size/drug effects MH - Oxidoreductases/metabolism MH - Phthalic Acids/*toxicity MH - Plasticizers/*toxicity MH - RNA/chemistry/genetics MH - Receptors, Cytoplasmic and Nuclear/*metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transcription Factors/*metabolism EDAT- 2003/09/11 05:00 MHDA- 2003/10/29 05:00 CRDT- 2003/09/11 05:00 PHST- 2003/09/11 05:00 [pubmed] PHST- 2003/10/29 05:00 [medline] PHST- 2003/09/11 05:00 [entrez] AID - S0300483X03002609 [pii] AID - 10.1016/s0300-483x(03)00260-9 [doi] PST - ppublish SO - Toxicology. 2003 Sep 30;191(2-3):211-25. doi: 10.1016/s0300-483x(03)00260-9.